Israel and Pfizer Reach Agreement for COVID-19 Vaccines
Israel has reached a landmark agreement with pharmaceutical giant Pfizer for the supply of COVID-19 vaccines. The deal involves the purchase of eight million additional doses of the Pfizer-BioNTech vaccine, boosting Israel`s chances of achieving herd immunity in the coming months.
The agreement comes after Israel began administering the Pfizer vaccine on December 20, 2020. The country has since been praised for its speedy rollout of the vaccine, with over 40% of the population having received at least one dose.
Under the new agreement, Israel will receive an additional eight million doses of the Pfizer vaccine, bringing the total number of doses purchased to 10 million. The vaccines will be delivered between April and July, allowing Israel to continue its mass vaccination campaign throughout the spring and early summer.
The agreement is part of Israel`s efforts to secure enough vaccines to reach herd immunity, which would involve vaccinating at least 70% of the population. Achieving herd immunity is seen as crucial for the country to reopen its economy and return to some sense of normalcy.
Israel has taken a proactive approach to securing COVID-19 vaccines, signing agreements with multiple manufacturers and investing heavily in its vaccination campaign. The country has also shared its data and experience with other countries, helping to accelerate the global vaccination effort.
The Pfizer-BioNTech vaccine has been shown to be highly effective at preventing COVID-19, with studies showing that it reduces the risk of infection by up to 95%. The vaccine has been approved for emergency use by regulatory authorities in countries around the world, including the US, EU, and Israel.
Despite the success of the vaccination campaign, Israel has continued to experience outbreaks of the virus, including the highly infectious B117 variant. The government has implemented strict lockdown measures to contain the spread of the virus, while also ramping up its vaccination efforts.
The Israel-Pfizer agreement is a significant step forward in the country`s fight against COVID-19, and a testament to the importance of proactive planning and partnership between governments and the private sector. As Israel continues to lead the world in vaccination efforts, it serves as a model for other countries to follow in the global battle against the pandemic.